| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerated coronary atherosclerosis not explained by traditional risk factors in 13% of young individuals
|
Head, Trajen
|
|
2019
|
208 |
C |
p. 47-54
|
artikel
|
| 2 |
Attitudes and considerations of patients with ST-elevation myocardial infarction toward participation in randomized clinical trials
|
Polcwiartek, Christoffer
|
|
2019
|
208 |
C |
p. 21-27
|
artikel
|
| 3 |
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study
|
Munkhaugen, John
|
|
2019
|
208 |
C |
p. 37-46
|
artikel
|
| 4 |
Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial
|
Held, Claes
|
|
2019
|
208 |
C |
p. 65-73
|
artikel
|
| 5 |
Editorial Board
|
|
|
2019
|
208 |
C |
p. iii
|
artikel
|
| 6 |
Frailty and multi-morbidities should not govern oral anticoagulation therapy prescribing for patients with atrial fibrillation
|
Fawzy, Ameenathul M
|
|
2019
|
208 |
C |
p. 120-122
|
artikel
|
| 7 |
Home monitoring with IT-supported specialist management versus home monitoring alone in patients with heart failure: Design and baseline results of the SUPPORT-HF 2 randomized trial
|
|
|
2019
|
208 |
C |
p. 55-64
|
artikel
|
| 8 |
Information for Readers
|
|
|
2019
|
208 |
C |
p. iv
|
artikel
|
| 9 |
Modes of death and prognostic outliers in chronic heart failure
|
Canepa, Marco
|
|
2019
|
208 |
C |
p. 100-109
|
artikel
|
| 10 |
Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial
|
Alexander, Karen P.
|
|
2019
|
208 |
C |
p. 123-131
|
artikel
|
| 11 |
Secular trends in success rate of catheter ablation for atrial fibrillation: The SMASH-AF cohort
|
Perino, Alexander C.
|
|
2019
|
208 |
C |
p. 110-119
|
artikel
|
| 12 |
Sex differences in management and outcomes of patients with stable symptoms suggestive of coronary artery disease: Insights from the PROMISE trial
|
Pagidipati, Neha J.
|
|
2019
|
208 |
C |
p. 28-36
|
artikel
|
| 13 |
Table of Contents
|
|
|
2019
|
208 |
C |
p. i-ii
|
artikel
|
| 14 |
The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design
|
Lambrakis, Kristina
|
|
2019
|
208 |
C |
p. 11-20
|
artikel
|
| 15 |
The association of pre- and posthospital medication adherence in myocardial infarction patients
|
Doll, Jacob A.
|
|
2019
|
208 |
C |
p. 74-80
|
artikel
|
| 16 |
The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction
|
Gibson, C. Michael
|
|
2019
|
208 |
C |
p. 81-90
|
artikel
|
| 17 |
The prognostic value of various biomarkers in adults with pulmonary hypertension; a multi-biomarker approach
|
Geenen, Laurie W.
|
|
2019
|
208 |
C |
p. 91-99
|
artikel
|
| 18 |
Twenty-five year trends (1986-2011) in hospital incidence and case-fatality rates of ventricular tachycardia and ventricular fibrillation complicating acute myocardial infarction
|
Tran, Hoang V.
|
|
2019
|
208 |
C |
p. 1-10
|
artikel
|
Tijdschrift beschrijving